Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+Status

被引:16
|
作者
Lu, Hecheng [1 ,2 ]
Yin, Jiandong [2 ]
机构
[1] Northeastern Univ, Sch Med & Bioinformat Engn, Shenyang, Peoples R China
[2] China Med Univ, ShengJing Hosp, Dept Radiol, Shenyang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
breast cancer; receiver operating characteristic; immunohistochemistry; magnetic resonance imaging; gene expression; IN-SITU HYBRIDIZATION; CONTRAST-ENHANCED MRI; NEOADJUVANT CHEMOTHERAPY; GENE AMPLIFICATION; MOLECULAR SUBTYPES; FEATURE-SELECTION; CANCER; HETEROGENEITY; EXPRESSION; FEATURES;
D O I
10.3389/fonc.2020.00543
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast tumor heterogeneity is related to risk factors that lead to aggressive tumor growth; however, such heterogeneity has not been thoroughly investigated. Purpose: To evaluate the performance of texture features extracted from heterogeneity subregions on subtraction MRI images for identifying human epidermal growth factor receptor 2 (HER2) 2+ status of breast cancers. Materials and Methods: Seventy-six patients with HER2 2+ breast cancer who underwent dynamic contrast-enhanced magnetic resonance imaging were enrolled, including 42 HER2 positive and 34 negative cases confirmed by fluorescence in situ hybridization. The lesion area was delineated semi-automatically on the subtraction MRI images at the second, fourth, and sixth phases (P-1, P-2, and P-3). A regionalization method was used to segment the lesion area into three subregions (rapid, medium, and slow) according to peak arrival time of the contrast agent. We extracted 488 texture features from the whole lesion area and three subregions independently. Wrapper, least absolute shrinkage and selection operator (LASSO), and stepwise methods were used to identify the optimal feature subsets. Univariate analysis was performed as well as support vector machine (SVM) with a leave-one-out-based cross-validation method. The area under the receiver operating characteristic curve (AUC) was calculated to evaluate the performance of the classifiers. Results: In univariate analysis, the variance from medium subregion at P-2 was the best-performing feature for distinguishing HER2 2+ status (AUC = 0.836); for the whole lesion region, the variance at P-2 achieved the best performance (AUC = 0.798). There was no significant difference between the two methods (P = 0.271). In the machine learning with SVM, the best performance (AUC = 0.929) was achieved with LASSO from rapid subregion at P-2; for the whole region, the highest AUC value was 0.847 obtained at P-2 with LASSO. The difference was significant between the two methods (P = 0.021). Conclusion: The texture analysis of heterogeneity subregions based on intratumoral regionalization method showed potential value for recognizing HER2 2+ status in breast cancer.
引用
收藏
页数:12
相关论文
共 50 条
  • [11] DCE-MRI based deep learning analysis of intratumoral subregion for predicting Ki-67 expression level in breast cancer
    Ding, Zhimin
    Zhang, Chengmeng
    Xia, Cong
    Yao, Qi
    Wei, Yi
    Zhang, Xia
    Zhao, Nannan
    Wang, Xiaoming
    Shi, Suhua
    MAGNETIC RESONANCE IMAGING, 2025, 119
  • [12] Preliminary study on discriminating HER2 2+amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI
    Song, Lirong
    Lu, Hecheng
    Yin, Jiandong
    PLOS ONE, 2020, 15 (06):
  • [13] DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers
    Fan, Ming
    Cheng, Hu
    Zhang, Peng
    Gao, Xin
    Zhang, Juan
    Shao, Guoliang
    Li, Lihua
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2018, 48 (01) : 237 - 247
  • [14] Using Features from Tumor Subregions of Breast DCE-MRI for Estrogen Receptor Status Prediction
    Chaudhury, Baishali
    Zhou, Mu
    Goldgof, Dmitry B.
    Hall, Lawrence O.
    Gatenby, Robert A.
    Gillies, Robert J.
    Drukteinis, Jennifer S.
    2014 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN AND CYBERNETICS (SMC), 2014, : 2624 - 2629
  • [15] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [16] Preliminary study on DCE-MRI radiomics analysis for differentiation of HER2-low and HER2-zero breast cancer
    Yin, Liang
    Zhang, Yun
    Wei, Xi
    Shaibu, Zakari
    Xiang, Lingling
    Wu, Ting
    Zhang, Qing
    Qin, Rong
    Shan, Xiuhong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [17] HER2 in Gastric Cancer: A Comprehensive Analysis Combining Meta-Analysis and DCE-MRI Radiomics
    Shen, Liyijing
    Li, Yaoqing
    Huang, Huizhen
    Lu, Zengxin
    Chen, Bo
    CANCER CONTROL, 2024, 31
  • [18] The Clinical Study of Intratumoral and Peritumoral Radiomics Based on DCE-MRI for HER-2 Positive and Low Expression Prediction in Breast Cancer
    Shang, Yiyan
    Wang, Yunxia
    Guo, Yaxin
    Li, Shunian
    Liao, Jun
    Hai, Menglu
    Wang, Meiyun
    Tan, Hongna
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16 : 957 - 972
  • [19] HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma
    Purdie, Colin A.
    Jordan, Lee B.
    McCullough, Jean B.
    Edwards, Sharon L.
    Cunningham, Joan
    Walsh, Miriam
    Grant, Andrew
    Pratt, Norman
    Thompson, Alastair M.
    HISTOPATHOLOGY, 2010, 56 (06) : 702 - 707
  • [20] Radiomics Analysis of Multi-Phase DCE-MRI in Predicting Tumor Response to Neoadjuvant Therapy in Breast Cancer
    Peng, Shuyi
    Chen, Leqing
    Tao, Juan
    Liu, Jie
    Zhu, Wenying
    Liu, Huan
    Yang, Fan
    DIAGNOSTICS, 2021, 11 (11)